Drug · DIN 02427826
APO-EZETIMIBE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 14, 2026; first marketed September 23, 2014.
- Drug Identification Number (DIN)
- 02427826
- Company (DIN owner)
- Apotex Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Ezetimibe C10AX09
- Class
- Human
- Record last updated
- August 18, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| EZETIMIBE | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 22, 2019: NOC 22568Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies. revisions to the product monograph, package insert and inner and outer labels
- October 26, 2016: NOC 18611Abbreviated New Drug Submission (ANDS)
- September 15, 2014: NOC 16090Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies